The lower sphincter, where the esophagus meets the stomach
Achalasia
Also called esophageal achalasia, achalasia cardia.
- What fails
- Will not open to let food into the stomach, and the pushing wave stops
- Test to ask for
- A pressure test while swallowing (manometry), plus a camera examination (endoscopy)
- Who to ask
- Gastroenterologist
- Who gets it
- Most often starts between 30 and 60
What do the test names and numbers mean?
- Manometry
- A thin tube measures pressure as you swallow.
- Endoscopy
- A small camera examines the food pipe.
- Videofluoroscopy
- A moving X-ray taken while you swallow.
- 95% confidence interval (CI)
- A statistical range showing uncertainty around a study estimate. It is not a promise about an individual person.
- Median and IQR
- The median is the middle value. The interquartile range (IQR) contains the middle half of the results.
- Odds ratio
- A comparison of odds between two groups. It is not the same as a difference in percentage points.
What it is
Achalasia is a problem at the bottom of the esophagus. Where the esophagus meets the stomach there is a second ring of muscle, the lower esophageal sphincter, which is supposed to relax every time you swallow. In achalasia, the nerves that tell it to relax are lost. The ring stays shut, and the waves that normally push food down the esophagus stop as well1. Food and drink pile up above the closed ring and drain slowly, if at all.
Nobody knows what causes it1,2. It is rare. A 2024 review put the number of new cases at a little under 1 per 100,000 people a year, and rising, probably because doctors are recognising it more often3. It affects men and women equally and most often starts between the ages of 30 and 601.
It has also been studied for a long time. The search used on this site finds 2,891 achalasia papers in PubMed from before 1990 alone4.
What it feels like
Food stops on the way down, somewhere behind the breastbone. It is usually solid food first, and then drinks too. It usually gets slowly worse over months or years1,5.
Food comes back up, and it tastes like food rather than sour acid. There can be a lot of saliva with it5. Lying down makes this worse, so it can happen at night, and food that comes up while you sleep can be breathed in5. People often lose weight, usually 5 to 10 kg5.
Many people find their own tricks for getting food down: eating slowly, raising their arms, or arching their back5. Chest pain and heartburn are common as well1.
What tells it apart from the ones next to it
From reflux. This is the big one. Between 27 and 42 percent of people with achalasia have heartburn, so many are first told they have reflux and given acid medicine, which cannot open a valve that will not relax. The wrong diagnosis often delays the right one1. In a study of 300 patients, 42% had been given at least one wrong diagnosis first (26% one, 16% more than one), most often reflux6. The American College of Gastroenterology recommends testing for achalasia when suspected reflux does not get better with acid medicine1.
From spasm. On manometry, achalasia is defined by a lower sphincter that fails to relax. In distal esophageal spasm the sphincter relaxes normally7,8. One type of achalasia, type III, also has spasm-like squeezing, and some experts see the two as neighbours on the same spectrum9.
From the upper sphincter problems (A-CPD and Zenker's). Trouble with drinks as well as food points lower down. Where you feel it is only a rough guide, though, because achalasia can be felt as high as the neck10.
From something more serious. A cancer near the top of the stomach can imitate achalasia. It is more likely in people over 55 who have lost a lot of weight quickly over a short time. That is why everyone with suspected achalasia should have an endoscopy1,2.
How it gets confirmed
- High-resolution manometry. A thin tube goes through the nose and down into the stomach and measures pressure along the esophagus while you take small sips of water. It is the gold standard, and it also tells which of the three types of achalasia you have, which affects treatment1,7.
- Barium swallow (esophagram). You drink barium and X-rays are taken, ideally at 1, 2 and 5 minutes, which is called a timed barium esophagram. The classic picture is a widened esophagus narrowing to a point at the bottom, often described as a bird's beak1.
- Upper endoscopy. A camera on a flexible tube. It is mainly there to rule out cancer, and it often looks normal early in the disease2.
- FLIP (functional lumen imaging probe). A newer test done during endoscopy that measures how well the bottom of the esophagus stretches open. It can help when manometry cannot be done1.
The person to ask for is a gastroenterologist, and the test to ask about by name is high-resolution manometry.
How it gets treated
None of the treatments cures achalasia. They all work by opening the bottom of the esophagus so food can drain1.
- Pneumatic dilation. Under sedation, a balloon is placed across the sphincter and inflated to stretch and tear the muscle. It may need repeating. The risk of a tear through the wall is about 2%1.
- Heller myotomy. Keyhole surgery through the abdomen that cuts the muscle of the sphincter, usually together with a partial wrap of the stomach (called a Dor or Toupet) to limit reflux afterwards1.
- POEM (peroral endoscopic myotomy). The same cut made from the inside, through the mouth, with no cuts in the skin. Reflux afterwards is more common than with the other two, and some people need acid medicine long term1.
- Botox. 100 units injected into the sphincter during an endoscopy. It wears off, so it is mainly for people who cannot have the other treatments1.
- Pills. Calcium channel blockers or nitrates. These are the least effective option and often cause side effects such as headaches1.
What the evidence says
- Dilation and Heller myotomy work about equally well. In a randomized trial of 201 people, 86% after dilation and 90% after surgery were doing well at two years, which was not a real difference11. At five years it was 82% and 84%12.
- POEM matches Heller myotomy, with more reflux. In a randomized trial of 221 people, 83% after POEM and 82% after surgery were doing well at two years (difference 1.4 points, 95% CI -8.7 to 11.4)13, and 75% and 71% at five years14. At two years, 44% of the POEM group had reflux damage on endoscopy, against 29% after surgery13.
- POEM beat dilation in one trial. In 133 people, 92% after POEM and 54% after dilation were doing well at two years (difference 38 points, 95% CI 22 to 52)15, and 81% against 40% at five years16. The trial allowed only one round of dilation, while many centres dilate again with a larger balloon. Counting one extra dilation, success with dilation rose to 76%1.
- Botox fades. About 79% have relief in the first month and about 41% still do at a year1.
- It takes a long time to diagnose. In 278 patients in Italy the median wait from first symptom to diagnosis was 24 months17. In 300 patients in Germany the mean was 4.7 years6.
- There is a cancer risk, but it is small. Achalasia raises the risk of one kind of esophageal cancer many times over. The absolute risk is still low, and the ACG guideline does not recommend routine screening1.
Studies to ask about
Get email alerts about new potential studies
28 studies are listed as recruiting or not yet recruiting for Achalasia. See the studies and follow updates.
Often confused with
Sources
Every number on this page comes from one of these. Numbers in the text link here.
- Vaezi MF, Pandolfino JE, Yadlapati RH et al.. ACG Clinical Guidelines: Diagnosis and Management of Achalasia. Am J Gastroenterol. 2020. PMID 32773454
- Oude Nijhuis RAB, Zaninotto G, Roman S et al.. European guidelines on achalasia: United European Gastroenterology and European Society of Neurogastroenterology and Motility recommendations. United European Gastroenterol J. 2020. PMID 32213062
- Lee K, Hong SP, Yoo IK et al.. Global trends in incidence and prevalence of achalasia, 1925-2021: A systematic review and meta-analysis. United European Gastroenterol J. 2024. PMID 38430514
- EMBL-EBI. Europe PMC REST API, search endpoint. Europe PMC.
- Patel DA, Kim HP, Zifodya JS et al.. Idiopathic (primary) achalasia: a review. Orphanet J Rare Dis. 2015. PMID 26198208
- Müller M, Förschler S, Wehrmann T et al.. Atypical presentations and pitfalls of achalasia. Dis Esophagus. 2023. PMID 37158189
- Yadlapati R, Kahrilas PJ, Fox MR et al.. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©. Neurogastroenterol Motil. 2021. PMID 33373111
- Roman S, Hebbard G, Jung KW et al.. Chicago Classification Update (v4.0): Technical review on diagnostic criteria for distal esophageal spasm. Neurogastroenterol Motil. 2021. PMID 33666299
- Patel DA, Yadlapati R, Vaezi MF. Esophageal Motility Disorders: Current Approach to Diagnostics and Therapeutics. Gastroenterology. 2022. PMID 35227779
- Mari A, Calabrese F, Pasta A et al.. Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility. United European Gastroenterol J. 2025. PMID 40543044
- Boeckxstaens GE, Annese V, des Varannes SB et al.. Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med. 2011. PMID 21561346
- Moonen A, Annese V, Belmans A et al.. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2016. PMID 26614104
- Werner YB, Hakanson B, Martinek J et al.. Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia. N Engl J Med. 2019. PMID 31800987
- Hugova K, Mares J, Hakanson B et al.. Per-oral endoscopic myotomy versus laparoscopic Heller's myotomy plus Dor fundoplication in patients with idiopathic achalasia: 5-year follow-up of a multicentre, randomised, open-label, non-inferiority trial. Lancet Gastroenterol Hepatol. 2025. PMID 40112837
- Ponds FA, Fockens P, Lei A et al.. Effect of Peroral Endoscopic Myotomy vs Pneumatic Dilation on Symptom Severity and Treatment Outcomes Among Treatment-Naive Patients With Achalasia: A Randomized Clinical Trial. JAMA. 2019. PMID 31287522
- Kuipers T, Ponds FA, Fockens P et al.. Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia: 5-year follow-up of a randomised controlled trial. Lancet Gastroenterol Hepatol. 2022. PMID 36206786
- Pasta A, Calabrese F, Ghezzi A et al.. Diagnostic delay in achalasia. Dig Liver Dis. 2024. PMID 38762352